EA200000922A1 - Производные аминоантрациклинона и их применение в лечении амилоидоза - Google Patents

Производные аминоантрациклинона и их применение в лечении амилоидоза

Info

Publication number
EA200000922A1
EA200000922A1 EA200000922A EA200000922A EA200000922A1 EA 200000922 A1 EA200000922 A1 EA 200000922A1 EA 200000922 A EA200000922 A EA 200000922A EA 200000922 A EA200000922 A EA 200000922A EA 200000922 A1 EA200000922 A1 EA 200000922A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydrogen
hydroxy
amyloidosis
formula
treatment
Prior art date
Application number
EA200000922A
Other languages
English (en)
Other versions
EA003333B1 (ru
Inventor
Тициано Бандьера
Даньеле Фанчелли
Марио Варази
Микеле Карузо
Жаклин Лансен
Антонино Сварато
Original Assignee
Фармация Энд Апджон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон С.П.А. filed Critical Фармация Энд Апджон С.П.А.
Publication of EA200000922A1 publication Critical patent/EA200000922A1/ru
Publication of EA003333B1 publication Critical patent/EA003333B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Соединение формулы (1), в которой Rпредставляет собой водород, гидрокси, группу формулы OR, в которой Rозначает C-C-алкил, C-C-алкенил; Rпредставляет собой водород, гидрокси, диэтиламин, пиперидин, тетрагидропиридин или морфолин, и либо R, взятый в отдельности, означает водород или гидрокси и Rи R, взятые в отдельности, независимо означают водород, гидрокси или, взятые вместе с углеродным атомом, означают карбонильную группу; или Rи R, взятые вместе, означают группу формулы (A), в которой Rи Rпредставляют собой C-C-алкил и Rозначает водород; Rпредставляет собой водород или фенильную группу, необязательно замещенную метилом, метокси или галогеном, и его фармацевтически приемлемую соль применяют в лечении амилоидоза. Также описаны способы получения и фармацевтические композиции.Отчет о международном поиске был опубликован 1999.10.21.
EA200000922A 1998-03-10 1999-02-25 Производные аминоантрациклинона и их применение в лечении амилоидоза EA003333B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805080.0A GB9805080D0 (en) 1998-03-10 1998-03-10 Amino anthracyclinone derivatives
PCT/EP1999/001300 WO1999046254A2 (en) 1998-03-10 1999-02-25 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis

Publications (2)

Publication Number Publication Date
EA200000922A1 true EA200000922A1 (ru) 2001-04-23
EA003333B1 EA003333B1 (ru) 2003-04-24

Family

ID=10828304

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000922A EA003333B1 (ru) 1998-03-10 1999-02-25 Производные аминоантрациклинона и их применение в лечении амилоидоза

Country Status (23)

Country Link
US (1) US6268362B1 (ru)
EP (1) EP1062206B1 (ru)
JP (1) JP2002506066A (ru)
KR (1) KR100603798B1 (ru)
CN (1) CN1113867C (ru)
AR (1) AR019831A1 (ru)
AT (1) ATE264302T1 (ru)
AU (1) AU755754B2 (ru)
BR (1) BR9908057A (ru)
CA (1) CA2321834A1 (ru)
DE (1) DE69916438D1 (ru)
EA (1) EA003333B1 (ru)
GB (1) GB9805080D0 (ru)
HU (1) HUP0101046A3 (ru)
ID (1) ID26084A (ru)
IL (1) IL137677A (ru)
NO (1) NO317260B1 (ru)
NZ (1) NZ506945A (ru)
PL (1) PL193245B1 (ru)
TW (1) TW528751B (ru)
UA (1) UA51838C2 (ru)
WO (1) WO1999046254A2 (ru)
ZA (1) ZA991839B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110264A1 (it) * 2011-05-27 2012-11-28 Univ Degli Studi Milano Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi ss amiloidi (ass).

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110289A (en) 1993-08-06 1998-01-04 Policlinico San Matteo Istitut Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis
GB9416007D0 (en) 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9516349D0 (en) 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives
GB9613433D0 (en) 1996-06-26 1996-08-28 Pharmacia Spa Fluoro labelled anthracyclinone and anthracycline derivatives

Also Published As

Publication number Publication date
AU755754B2 (en) 2002-12-19
EP1062206B1 (en) 2004-04-14
CN1291977A (zh) 2001-04-18
IL137677A (en) 2005-08-31
KR20010041737A (ko) 2001-05-25
UA51838C2 (ru) 2002-12-16
IL137677A0 (en) 2001-10-31
NZ506945A (en) 2002-06-28
WO1999046254A3 (en) 1999-10-21
EP1062206A2 (en) 2000-12-27
PL344086A1 (en) 2001-09-24
TW528751B (en) 2003-04-21
PL193245B1 (pl) 2007-01-31
US6268362B1 (en) 2001-07-31
KR100603798B1 (ko) 2006-07-25
HUP0101046A3 (en) 2002-12-28
AU2930899A (en) 1999-09-27
ZA991839B (en) 1999-12-22
JP2002506066A (ja) 2002-02-26
CN1113867C (zh) 2003-07-09
DE69916438D1 (de) 2004-05-19
NO20004406D0 (no) 2000-09-04
WO1999046254A2 (en) 1999-09-16
ATE264302T1 (de) 2004-04-15
AR019831A1 (es) 2002-03-20
HUP0101046A2 (hu) 2001-08-28
GB9805080D0 (en) 1998-05-06
NO317260B1 (no) 2004-09-27
BR9908057A (pt) 2000-10-31
CA2321834A1 (en) 1999-09-16
NO20004406L (no) 2000-10-30
ID26084A (id) 2000-11-23
EA003333B1 (ru) 2003-04-24

Similar Documents

Publication Publication Date Title
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
HUP0400636A2 (hu) Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk
EA200200873A1 (ru) Новые пиперазиновые производные
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
NO996108L (no) 9-oksinerytromycinderivater
EA200100983A1 (ru) Производные 13-метилэритромицина
ES538418A0 (es) Un derivado de indol-3-carboxamida
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
DE69709493T2 (de) Substituierte Indazolderivate
PT992509E (pt) Novos derivados macrolidos
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
BG104447A (en) Biphenylamidine derivatives
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
EA200000922A1 (ru) Производные аминоантрациклинона и их применение в лечении амилоидоза
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO944577L (no) Hemming av effekten av amyloidogene proteiner
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
NZ335631A (en) Antipsychotic (neuroleptic) piperidine derivatives
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ RU